Bottom line
EDGE vs VPMCX: the short answer
EDGE (MRBL Enhanced Equity ETF) and VPMCX (Vanguard PRIMECAP Fund) are both etfs.
But VPMCX is far broader, holding 173 positions to 4 for EDGE, so beyond the top names it adds exposure EDGE doesn't have.
VPMCX is cheaper at 0.35% vs 0.74% — a difference of $39 a year per $10,000 invested.
Updated Nov 19, 2026
EDGE vs VPMCX side by side
| EDGE | VPMCX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | ARK Invest | Vanguard |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.74% | 0.35% |
| Annual cost per $10k | $74 | $35 |
| 10-yr cost on $10k (prospectus) | $918 | $443 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +29.9% |
| 5-yr return (annualized) | — | +14.3% |
| 10-yr return (annualized) | — | +15.2% |
| Best quarter | — | +17.3% |
| Worst quarter | — | −20.2% |
| Net assets (fund) | $8.4M | $96.1B |
| Number of holdings | 4 | 173 |
| Portfolio turnover | % | 11% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
EDGE and VPMCX share none of their top holdings.
EDGE top 10
- Spy 01/15/2027 200.01 C — 93.27%
- First American Government Obligations Fund — 8.45%
- Xsp 06/18/2026 757.01 C — -0.13%
- Spx 06/18/2026 7570.01 C — -1.57%
VPMCX top 10
- Micron Technology Inc — 13.50%
- Intel Corp — 6.80%
- Eli Lilly & Co — 6.76%
- KLA Corp — 3.85%
- Alphabet Inc — 3.52%
- AstraZeneca PLC — 2.35%
- NVIDIA Corp — 2.33%
- Amazon.com Inc — 2.05%
- Tesla Inc — 1.89%
- Biogen Inc — 1.88%
FAQ
What is the difference between EDGE and VPMCX?
EDGE (MRBL Enhanced Equity ETF) and VPMCX (Vanguard PRIMECAP Fund) are both etfs. But VPMCX is far broader, holding 173 positions to 4 for EDGE, so beyond the top names it adds exposure EDGE doesn't have.
Which is cheaper, EDGE or VPMCX?
VPMCX has the lower expense ratio (0.35%).
Should I own both EDGE and VPMCX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.